Artículos por temáticas

Correction to: Aberrant Salient and Corticolimbic Connectivity in Hypersexual Parkinson's Disease, by Mata-Marín, et al. Brain Connect 2021;11(8):639-650; doi: 10.1089/brain.2020.0868

Brain Connect. 2022 May;12(4):398. doi: 10.1089/brain.2020.0868.correx. Epub 2022 May 2.

Reply to: "An Exponential Rather Than Multistep Model of Parkinson's Disease Pathogenesis"

Le Heron C, MacAskill MR, Myall DJ.

Mov Disord. 2022 May;37(5):1107. doi: 10.1002/mds.28989. Epub 2022 Mar 28.

Reply to: "Increased Stroke Risk in Patients with Parkinson's Disease with LRRK2 Mutations"

Macías-García D, Periñán MT, Muñoz-Delgado L, Jesús S, Jimenez-Jaraba MV, Buiza-Rueda D, Bonilla-Toribio M, Adarmes-Gómez A, Carrillo F, Gómez-Garre P, Mir P.

Mov Disord. 2022 May;37(5):1119-1120. doi: 10.1002/mds.28995.

Current Therapies and Drug Development Pipeline in Lewy Body Dementia: An Update

MacDonald S, Shah AS, Tousi B.

Drugs Aging. 2022 May 27. doi: 10.1007/s40266-022-00939-w. Online ahead of print.

The subjective experience of family caregivers of people living with Parkinson's disease: a meta-ethnography of qualitative literature

Chen Y, Zhou W, Hou L, Zhang X, Wang Q, Gu J, Zhang R, Yang H.

Aging Clin Exp Res. 2022 May;34(5):959-970. doi: 10.1007/s40520-021-01995-9. Epub 2021 Oct 14.

Synuclein-One study: skin biopsy detection of phosphorylated α-synuclein for diagnosis of synucleinopathies

Gibbons CH, Freeman R, Bellaire B, Adler CH, Moore D, Levine T.

Biomark Med. 2022 May;16(7):499-509. doi: 10.2217/bmm-2021-0646. Epub 2022 Mar 11.

Promoting Gender Inclusivity: A Questionnaire for Women's Health Factors in Parkinson's Disease

Rao SC, Pattipati S, Salim A, Gutierrez N, Naito A, Ghosh K, De Leon M, Mata I.

Mov Disord. 2022 May;37(5):1112-1113. doi: 10.1002/mds.29020.

Reply to: "Promoting Gender Inclusivity: A questionnaire for Women's Health Factors in Parkinson's Disease"

Subramanian I, Mathur S, Oosterbaan A, Flanagan R, Keener AM, Moro E.

Mov Disord. 2022 May;37(5):1113. doi: 10.1002/mds.29031.

Complexities and paradoxes in understanding the role of dopamine in incentive motivation and instrumental action: Exertion of effort vs. anhedonia

Salamone JD, Ecevitoglu A, Carratala-Ros C, Presby RE, Edelstein GA, Fleeher R, Rotolo RA, Meka N, Srinath S, Masthay JC, Correa M.

Brain Res Bull. 2022 May;182:57-66. doi: 10.1016/j.brainresbull.2022.01.019. Epub 2022 Feb 10.

Deciphering the prion-like behavior of pathogenic protein aggregates in neurodegenerative diseases

Yoshida S, Hasegawa T.

Neurochem Int. 2022 May;155:105307. doi: 10.1016/j.neuint.2022.105307. Epub 2022 Feb 15.

Managing Bipolar Disease Complicated with Psychosis in Conjunction with Polypharmacy, Parkinson's Disease, and Multiple Comorbidities

Irizarry R, Sosa Gomez A, Miles S, Tamayo Acosta J.

Case Rep Psychiatry. 2022 May 5;2022:3813929. doi: 10.1155/2022/3813929. eCollection 2022.

Early metabolic impairment as a contributor to neurodegenerative disease: Mechanisms and potential pharmacological intervention

Fakih W, Zeitoun R, AlZaim I, Eid AH, Kobeissy F, Abd-Elrahman KS, El-Yazbi AF.

Obesity (Silver Spring). 2022 May;30(5):982-993. doi: 10.1002/oby.23400.

Effects of subthalamic deep brain stimulation on non-motor symptoms of Parkinson's disease: A meta-analysis

Eghlidos Z, Rahimian Z, Vadiee G, Jahangiri S.

Acta Neurol Scand. 2022 May 25. doi: 10.1111/ane.13652. Online ahead of print.

TGF-β as a Key Modulator of Astrocyte Reactivity: Disease Relevance and Therapeutic Implications

Luo J.

Biomedicines. 2022 May 23;10(5):1206. doi: 10.3390/biomedicines10051206.

Assessment of GGC Repeat Expansion in GIPC1 in Patients with Parkinson's Disease

Pan Y, Xue J, Chen J, Zhang X, Tu T, Xiao Q, Huang W, Liu Q, Zhu L, Li J, Zhou X, Xu Q, Sun Q, Tan J, Yan X, Li J, Guo J, Tang B, Duan R, Liu Z.

Mov Disord. 2022 May 6. doi: 10.1002/mds.29041. Online ahead of print.